Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Stembanc Inc
FDA Inspection
•Stembanc Inc•August 31, 2009

Stembanc Inc – FDA Inspection, Aug 31, 2009

Record Details

This FDA Inspection record concerns Stembanc Inc, with an inspection on August 31, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Stembanc Inc
Inspection Date
August 31, 2009
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
View Company Profile

ID · 9b31a0a8-3cb3-44f7-9be2-7760ef9083e7

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
596205
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies

FDA Citations

10
  1. 21 CFR 1271.80(a)Birth mother sample not tested
  2. 21 CFR 1271.265(e)Documentation elements for activities
  3. 21 CFR 1271.195(a)(3)Aseptic processing---cleaning, disinfecting
  4. 21 CFR 1271.50(a)Determination based on screening and testing
  5. 21 CFR 1271.65(a)Improper release prevention--storage, I.D.
  6. 21 CFR 1271.47(a)Procedures for all other requirements
  7. 21 CFR 1271.230(a)Process validation procedures
  8. 21 CFR 1271.270(a)Records incomplete
  9. 21 CFR 1271.50(a)Responsible person to determine, document
  10. 21 CFR 1271.150(c)(1)(iii)Ensurane of compliance

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Stembanc Inc

5
DateClassificationOfficeProject area
June 6, 2024NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
September 23, 2021NAICenter for Biologics Evaluation and ResearchVaccines and Allergenic Products
February 12, 2014VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
February 4, 2013VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
April 27, 2010VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Stembanc Inc
  • FDA Inspection 1242190 - 2024-06-06
  • FDA Inspection 1153328 - 2021-09-23
  • FDA Inspection 862242 - 2014-02-12
  • FDA Inspection 814359 - 2013-02-04
  • FDA Inspection 659051 - 2010-04-27

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Stembanc Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.